“Some days I wake up and can’t think how far we’ve arrive,” said Dr. Doblin, 67, who now oversees the Multidisciplinary Affiliation for Psychedelic Experiments, a multimillion dollar investigate and advocacy empire that employs one hundred thirty neuroscientists, pharmacologists and regulatory professionals working to lay the groundwork for